Cell Therapeutics Enters Into Agreement to Acquire Pacritinib, a Novel Highly Selective JAK2
- 19 April 2012
Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.
© 2021- edbi. All rights reserved.